I Am Bhojpuriya

Tag: Thermo Fisher Scientific

  • Thermo Fisher Scientific expands its SARS-CoV-2 testing portfolio in India with a point-of-care testing platform

    The Accula System is an innovative platform that will accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care.

    Mumbai (Maharashtra) [India], June 15: Thermo Fisher Scientific today announced the introduction of the new and innovative Accula SARS-CoV-2 Test that delivers gold-standard reverse transcription-polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format.

    The Accula SARS-CoV-2 Test has received Emergency Use Authorization (EUA) from the United States (U.S.) Food and Drug Administration (FDA) for the detection of SARS-CoV-2 in Clinical Laboratory Improvement Amendments (CLIA)–waived environments.

    “Since the start of the pandemic, Thermo Fisher has acted quickly to provide support to the scientists and healthcare professionals at the frontlines of combating COVID-19,” said Amit Chopra, Managing Director, India, and South Asia, Thermo Fisher Scientific. “Thermo Fisher’s new testing platform combines the accuracy of RT-PCR with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays. The Accula SARS-CoV-2 Test is a natural extension to our existing offerings and will significantly help to meet the continuing demands for rapid and reliable COVID-19 testing in India.”

    RT-PCR testing is streamlined from start to finish using a fully integrated, single-use microfluidic test cassette and the reusable, palm-sized Accula Dock. The test uses nasal swab samples and provides reliable, qualitative results in approximately 30 minutes. The Accula SARS-CoV-2 Test is enabled by proprietary PCR technology that allows for reduced absolute temperatures and reduced temperature differentials—resulting in rapid exponential amplification while reducing overall thermocycling times.

    “The rapid Accula point-of-care test will open new avenues of personal and public testing without compromising on accuracy,” added Amit. “The introduction of the test in India is a demonstration of the impact our solutions have on human health during the pandemic, and far beyond.”

    In January 2021, Thermo Fisher acquired Mesa Biotech Inc., which developed the Accula SARS-CoV-2 Test to provide accurate and faster results at the point of care.

    For more information, please visit www.thermofisher.com

    Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies, or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon.

  • Thermo Fisher Scientific commits $10 million to support India’s fight against COVID-19

    Mumbai (Maharashtra) [India], May 12: Thermo Fisher Scientific, the world leader in serving science, has pledged $10 million as its contribution to India’s fight against COVID-19. As COVID-19 cases continue to escalate, this support aims to offer cash and urgently needed products to help the country in bringing the health crisis under control.

    As part of the commitment, the company is directing more than $1 million to non-governmental and non-profit organizations that are directly serving the people impacted by the pandemic. The remaining $9 million donations are extended in the form of COVID-19 testing products, personal protective equipment, and other critical supplies from across the businesses.

    In light of the severity of the situation in India, Amit Chopra, Managing Director, India & South Asia, Thermo Fisher Scientific said, “We are deeply concerned with the surge in COVID-19 cases in India. We realize our responsibility goes beyond serving our customers and extends to the actions we take to support our communities. At Thermo Fisher, we are leveraging our partnerships to swiftly mobilize resources to respond to the escalating testing and vaccine production needs in the country. In addition to these, we are partnering with several NGOs and remain steadfast in our commitment to serving our colleagues, customers, and society in India.”

    Furthermore, the company is ramping up the production of its recently launched CoviPath PT-PCR kits in its Bengaluru facility to support the ongoing testing drive in the country.

    “We deeply appreciate the generous support and encouragement from Thermo Fisher Scientific during the COVID-19 pandemic. Their commitment and support of 4.6M VTM tubes will strengthen the system of collection, transportation, and storage of COVID test samples.  This will greatly mitigate the pain and suffering of those most impacted”, said Mr. Amitabh Kant, CEO, NITI Aayog, and Government of India.

    Thermo Fisher Scientific is at the forefront in the response to the global COVID-19 pandemic. The company has established worldwide leadership in COVID-19 testing and is actively involved in supporting the research, development and production of vaccines and therapies. In addition, the company is also expanding its high-quality novel solutions while ensuring reliable supply chains to meet the unprecedented testing demands, to address the current and future challenges posed by the pandemic.

    About Thermo Fisher Scientific

    Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com/.